Clinical Trial Update: A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of single-agent pemetrexed disodium in patients with recurrent or persistent ovarian cancer or primary peritoneal cancer; results were posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Alimta (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-08-24